7.77  -0.31 (-3.84%)		10-24 14:57
Open: 8.2 High: 8.33 Volume: 463,496		Pre. Close: 8.08 Low: 7.69 Market Cap: 44(M)

Short term
Mid term
Targets	6-month :	11.47	1-year :	13.88
Resists	First :	9.82	Second :	11.89
Pivot price	8.07
Supports	First :	6.48	Second :	5.39
MAs	MA(5) :	7.65	MA(20) :	8.68
	MA(100) :	8.47	MA(250) :	7.7
MACD	MACD :	-0.6	Signal :	-0.5
%K %D	K(14,3) :	23.4	D(3) :	20.2
RSI	RSI(14): 46.2
52-week	High :	47.27	Low :	0.85

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ HYPD ] has closed above bottom band by 45.7%. Bollinger Bands are 48.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	8.15 - 8.19	8.19 - 8.24
Low:	7.02 - 7.05	7.05 - 7.09
Close:	8.01 - 8.08	8.08 - 8.15

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

Wed, 02 Jul 2025
Eyenovia, Inc. will Change its Ticker to HYPD from EYEN - MarketScreener

Wed, 02 Jul 2025
Eyenovia rebrands as Hyperion DeFi, changes ticker to HYPD - Investing.com

Wed, 02 Jul 2025
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc. - Stock Titan

Wed, 02 Jul 2025
Eyenovia, Inc. Rebrands to Hyperion DeFi, Inc. and Announces Nasdaq Trading Under "HYPD" Ticker - Nasdaq

Mon, 23 Jun 2025
Eyenovia Announces Closing of $50 Million Private - GlobeNewswire

Thu, 19 Jun 2025
Eyenovia’s $50 Million HYPE Treasury Strategy Is A Bold Bet On DeFi’s Future - Tekedia

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	10 (M)
Held by Insiders	4.41e+006 (%)
Held by Institutions	29.7 (%)
Shares Short	1,070 (K)
Shares Short P.Month	0 (K)

EPS	-2.581e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-60 %
Return on Assets (ttm)	666.8 %
Return on Equity (ttm)	-45.2 %
Qtrly Rev. Growth	44440 %
Gross Profit (p.s.)	0
Sales Per Share	-89.01
EBITDA (p.s.)	-1.24125e+006
Qtrly Earnings Growth	-28.9 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-20 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.09
Price to Cash Flow	2.64

Dividend	0
Forward Dividend	1.59e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.